Up
2005E-0234:
Patent Extension Application for Macugen (pegaptanib sodium), U.S.
Patent No. 6,051,698
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| APP1
|
| 06/15/2005
|
| 06/15/2005
|
| Private Industry
|
| Gilead Sciences, Inc.
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
| Signature:
|
| Barry J. Swanson
|
|
|
| LET1
|
| 06/15/2005
|
| 06/15/2005
|
| Federal Government
|
| U.S. Patent &
Trademark Office
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Karin Ferriter
|
|
Top | Up
Page last updated
June 24, 2005
kk![horizonal rule](https://webarchive.library.unt.edu/eot2008/20081026052138im_/http://www.fda.gov/graphics/blkpixel.gif)
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |